You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

DYNACIRC Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Dynacirc patents expire, and what generic alternatives are available?

Dynacirc is a drug marketed by Smithkline Beecham and Glaxosmithkline Llc and is included in two NDAs.

The generic ingredient in DYNACIRC is isradipine. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the isradipine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Dynacirc

A generic version of DYNACIRC was approved as isradipine by WATSON LABS TEVA on January 5th, 2006.

  Try a Trial

Drug patent expirations by year for DYNACIRC
Recent Clinical Trials for DYNACIRC

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institute on Drug Abuse (NIDA)Early Phase 1
University of Texas at AustinEarly Phase 1
The Parkinson Study GroupPhase 2

See all DYNACIRC clinical trials

US Patents and Regulatory Information for DYNACIRC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Smithkline Beecham DYNACIRC isradipine CAPSULE;ORAL 019546-001 Dec 20, 1990 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Glaxosmithkline Llc DYNACIRC CR isradipine TABLET, EXTENDED RELEASE;ORAL 020336-002 Jun 1, 1994 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Smithkline Beecham DYNACIRC isradipine CAPSULE;ORAL 019546-002 Dec 20, 1990 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Glaxosmithkline Llc DYNACIRC CR isradipine TABLET, EXTENDED RELEASE;ORAL 020336-001 Jun 1, 1994 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for DYNACIRC

See the table below for patents covering DYNACIRC around the world.

Country Patent Number Title Estimated Expiration
Sweden 445219 1,4-DIHYDROPYRIDINDERIVAT, FORFARANDE FOR FRAMSTELLNING DERAV SAMT FARMACEUTISK KOMPOSITION ⤷  Try a Trial
European Patent Office 0000150 DIHYDROPYRIDINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. ⤷  Try a Trial
Denmark 149855 ⤷  Try a Trial
Portugal 70601 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.